Fluor's Earnings Beat Is a Turnaround Story the Numbers Don't Support

The market celebrated Fluor Corporation on Thursday like it was a company that had finally turned the corner. Shares jumped nearly 17 percent, the biggest single-day move in months, after the engineering and construction firm reported a second-quarter adjusted EPS of $0.91 — well above the $0.70 consensus. Revenue of $4.3 billion beat estimates, segment profit more than doubled, and new awards of $6.1 billion for the quarter looked like proof the pipeline was accelerating.

I've been very surprised that the market has taken this result as evidence of a durable turnaround. The headline beat is real, but the structural numbers behind it don't tell a turnaround story at all.

The first problem is free cash flow. Fluor has burned through $330 million over the trailing twelve months. That's not a cyclical blip — it's a company that is losing cash on an operating basis and has been for most of the period. The Q2 operating cash flow alone was negative $317 million, a number partly inflated by a $357 million tax payment tied to the NuScale Power sale Fluor completed in April. Strip out that extraordinary cash event, and the underlying operating cash flow is less painful but still unimpressive: the company's TTM operating cash flow sits at negative $287 million. Free cash flow is not the foundation of a recovery trade.

Second, and this is the part the earnings-beat narrative skips entirely: Fluor cut its full-year adjusted EBITDA guidance. Before the quarter, management had projected $525 to $560 million. The new range is $500 to $525 million — the top end was removed entirely. The stated reason is the removal of the Mexico JV's expected second-half contribution, following its $175 million divestiture. That's a valid accounting adjustment, but it also means Fluor can't match its Q2 enthusiasm with forward commitment.

Third, look at the margins. Fluor's trailing gross margin is negative 1.6 percent. Operating margin is negative 2.7 percent. This is not a company that has restructured itself into a high-margin operator. The Q2 improvement in Energy Solutions — where segment profit jumped from $15 million to $88 million — was explicitly aided by "favorable close-out items on certain projects, including the former Mexico JV." Close-outs are lumpy, non-recurring adjustments. They don't recur in Q3 unless management can point to a structural change in project economics, and they haven't.

Now let's talk about what the market is actually pricing Fluor for. The stock at $57 implies a market cap of nearly $8 billion. The P/E on trailing earnings is about 22.7x. Forward, the market expects EPS to grow from $2.63 to $3.08 — and the forward P/E implied by that growth is roughly 18.5x. Those are not distressed-asset multiples. Those are multiples the market pays for companies with durable margin recovery and positive cash generation. Fluor has neither.

The backlog argument is the one the bulls lean on hardest, and I'll give them this: $26.9 billion in backlog, with 85 percent reimbursable, is an impressive order book. New awards of $6.1 billion in Q2 were more than triple the prior-year quarter, including a reimbursable EPC contract for the Centrus nuclear fuel enrichment facility and a limited notice to proceed on the LNG Canada Phase 2 expansion. The Mission Solutions segment alone pulled in $2.2 billion in new awards, up from $363 million a year ago.

But reimbursable work is a double-edged sword. It's lower-margin volume. It gives you revenue predictability and steady cash flow in theory, but it doesn't generate the margin expansion that justifies an 18.5x forward multiple. And the Energy Solutions backlog — where the higher-margin fee and EPC work lives — fell to $3.5 billion from $5.6 billion a year ago. The growth is happening in the lower-margin bucket. That's a structural issue, not a temporary timing gap.

Then there's the capital allocation story. Fluor returned $300 million to shareholders through buybacks in Q2 and is targeting $1.4 billion for the full year. That's aggressive for a company burning $330 million in trailing free cash flow. The $1.4 billion buyback program is being funded by $3 billion in cash and marketable securities on the balance sheet, supplemented by the $1.83 billion in investing cash flow from the NuScale sale over the first half. The company completed that sale in April and is now deploying the proceeds to repurchase stock. That's fine as a one-off capital event, but buybacks funded by asset liquidation are not the same as buybacks funded by cash flow. Dividends represent a commitment to shareholder returns that recurs every quarter; buybacks can be paused the moment cash flow turns ugly again. Fluor pays a negligible $0.10 per share annually — a 0.7 percent forward yield that signals the company isn't making a recurring commitment to income investors at all.

Compare that to AECOM, which trades at a lower P/E of roughly 19x and pays a 1.6 percent dividend. AECOM has a comparable engineering-construction footprint but a more established pattern of returning cash through dividends. Fluor's choice to rely on buybacks while operating cash flow is negative tells me management is betting the NuScale proceeds bridge the gap until operations improve. If they do, fine. If not, the buyback program evaporates — and shareholders are left with diluted value from a company that never committed to a recurring payout.

What's the strongest case for Fluor at $57? The Nuclear and advanced technology pipeline is real. The Centrus deal, the LNG Canada expansion, and $6.1 billion in quarterly awards suggest the front-end engineering work is converting into execution contracts. Mission Solutions profit rose to $44 million from $35 million a year ago. If Fluor can execute on these higher-margin reimbursable contracts without the cost blowups that plagued its first-quarter miss, there's a path to margin recovery in 2027.

But that's a thesis for 2027, not for the price at which the stock is trading today. The market has already priced in a margin recovery that the TTM data — negative gross margin, negative operating cash flow, negative free cash flow, and cut guidance — doesn't yet support. The Q2 beat was driven by close-out items and segment improvements that haven't proven durable. The 17 percent single-day surge took the stock to its 52-week high of $57.65, and I think that's where the euphoria outruns the evidence.

That being the case, I rate Fluor a Hold. The backlog and new awards give the stock a floor, and the $3 billion cash position provides a cushion. But buying a company at a 22.7x trailing P/E because one quarter's adjusted EPS beat — while the company's trailing free cash flow is deeply negative and management just cut its annual guidance — is the kind of narrative-driven trade that gets punished when the next quarter returns to reality. The turnaround story will only become convincing when operating cash flow turns positive, margins normalize above zero on a trailing basis, and management raises rather than cuts its EBITDA guidance. Until then, the market has confused a one-quarter beat with a structural recovery.

For investors looking at engineering and construction exposure, AECOM offers a more defensible entry: lower valuation, a real dividend, and no active cash burn. Fluor may yet prove the bulls right, but the evidence has to come from the cash flow statement, not the adjusted earnings headline.